Skip to content

Drug interactions

Mobocertinib + Pimozide

Severity: Major

Mobocertinib and Pimozide: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Mobocertinib prolongs the QT interval and also induces CYP3A4, which may reduce pimozide exposure and effect. The combination adds torsades risk while making the pimozide dose unpredictable.

What this interaction means in plain words

Mobocertinib and Pimozide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Additive QT prolongation combined with CYP3A4 induction by mobocertinib that lowers pimozide levels.

What to do

Avoid coadministration and select an alternative to pimozide. If it cannot be avoided, monitor ECG and electrolytes closely and follow label dose reduction guidance for mobocertinib.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mobocertinib and Pimozide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Mobocertinib with Pimozide?

MediHelp rates the interaction as major. Mobocertinib and Pimozide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Mobocertinib prolongs the QT interval and also induces CYP3A4, which may reduce pimozide exposure and effect. The combination adds torsades risk while making the pimozide dose unpredictable.

How serious is the interaction between Mobocertinib and Pimozide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid coadministration and select an alternative to pimozide. If it cannot be avoided, monitor ECG and electrolytes closely and follow label dose reduction guidance for mobocertinib.

What other medicines interact with Pimozide?

MediHelp also lists interactions of Pimozide with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Pimozide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in